drugset / Trial / NCT07126990
Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma
Phase 1/2
Enrolling by invitation
40 enrolled
Xiaorong Wu
Beijing Bio-Targeting Therapeutics Technology Co., Ltd · collab
NaSingle-groupOpen-labelTreatment
Summary
Clinical study of a novel oncolytic virus Ad-TD-nsIL12 in the treatment of primary high-grade glioma
Timeline
- Start
- 2025-02-12
- Primary completion
- 2028-08-30
- Completion
- 2028-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ad-TD-nsIL12 | Unknown | 1e+10 unknown | Other |